World’s first anti-ageing gene therapy trial begins as ER-100 is injected into a human eye, testing partial cellular reprogramming to restore vision and fight ageing

The gene-therapy trial aims to treat glaucoma by rejuvenating cells in the optic nerve. Plus, the mystery of how things freeze and encouragement to go out into the sunlight.

The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate ageing cells.

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.

It'll be the first time ER-100 technology they claim can reverse aging in cells has been tested on a human

Life Biosciences ha annunciato di aver somministrato la sua terapia a base di riprogrammazione epigenetica parziale al primo essere umano in assoluto

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

El avance, destacado por el especialista en longevidad Eric Topol, marca el inicio de un ensayo en Estados Unidos donde se busca revertir el envejecimiento celular activando genes…

An eagerly awaited and controversial clinical trial to 'wind back the clock' on aging cells in the eye and restore them to a more youthful state has officially begun.

A US biotechnology company has tested a gene therapy designed to reverse ageing in humans for the first time.

World’s first anti-ageing gene therapy trial begins as ER-100 is injected into a human eye, testing partial cellular reprogramming to restore vision and fight ageing

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.